patient-safety
(8)
Drew Ladner
Drew Ladner is the founding Chairman and CEO of Pascal Metrics, a Washington, D.C. and Austin-based patient safety company that uses real-time EHR data, clinically validated adverse-event outcomes, and machine learning to catch preventable harm in hospitals before it compounds. Since 2007 he has built Pascal into a U.S.-certified Patient Safety Organization serving hundreds of healthcare systems worldwide, with clients identifying roughly 10x more serious harm than legacy methods. Before healthcare, he was CIO of the U.S. Treasury's $2.6 billion IT organization, a general manager at open-source pioneer JBoss, and an operator across Netscape, AOL Time Warner, and microfinance in East Africa. He holds an MBA from Harvard, an MA in theology from Oxford, and a BSFS from Georgetown.
Rich Vogel
Rich Vogel is the US CEO of Nervio, an Israeli HealthTech startup building the first AI platform designed specifically for intraoperative neurophysiological monitoring (IONM). A board-certified neurophysiologist with PhDs in both neuroscience and psychology, Vogel is a two-time elected president of the American Society of Neurophysiological Monitoring (ASNM) and one of the most widely recognized voices in the field. He has given more than a thousand talks across clinical, academic, and professional audiences, and now leads Nervio's push to turn raw streams of surgical brain-and-spine signals into real-time alerts that help operating-room teams catch neurologic risk earlier.
Sebby Borriello
Sebby Borriello is a pharmaceutical and medical-device commercialization veteran with 30-plus years of go-to-market leadership. After 25 years at Johnson & Johnson across wound management, biosurgery and aesthetics, he helped turn South Korea's SK Life Science from an R&D-only shop into a fully integrated US pharma company, leading the 2020 launch of its first FDA-approved drug, the epilepsy treatment XCOPRI. He later advised and joined Carmell Therapeutics as Chief Business Officer, and today serves as Executive Vice President and Chief Commercial Officer at MIDAS Healthcare Solutions, a New York startup tackling medication diversion and drug-waste accountability through its MidasVIEW platform and Anytime Witness video-verification technology.
Patricia "Trish" Henwood
Patricia "Trish" Henwood, MD, FACEP is an emergency physician who runs quality and safety across an 18-hospital system as Executive Vice President and Chief Clinical Officer of Jefferson Health in Philadelphia. Before the C-suite, she carried a portable ultrasound probe into an Ebola treatment unit in Liberia and built training programs that put imaging in the hands of clinicians in Rwanda, Uganda, Tanzania and beyond. She founded the nonprofit PURE to bring point-of-care ultrasound to resource-limited settings, published her bedside Ebola work in the New England Journal of Medicine, and now applies the same systems thinking to closing care gaps for vulnerable populations at home.
William Gilbert
William Gilbert is a senior healthcare executive associated with Regional Medical Center of San Jose, the East San Jose hospital long operated within HCA Healthcare's Good Samaritan Health System. His LinkedIn profile lists CEO-level leadership at the medical center, an institution known for its Level II trauma program, comprehensive stroke designation, STEMI receiving status and Leapfrog top-quartile patient safety recognition.
Mohammad Noshad
Mohammad Noshad is Co-Founder and CEO of Shyld AI, the company behind the world's first AI-driven autonomous UV-C disinfection system for hospitals. A Harvard-trained researcher with a PhD from the University of Virginia, Noshad pivoted from academic work in signal processing and optical communications to building technology that attacks the $50+ billion annual problem of hospital-acquired infections. Shyld AI's ceiling-mounted devices use multimodal sensors and edge AI to autonomously identify contaminated surfaces and inactivate pathogens - killing MRSA in 10 seconds from 6.5 feet away - with pilots running at Stanford Health Care and Loma Linda University Medical Center. Noshad is also co-founder of Wodio.AI and a Strategic Advisor at Field AI.
Eduardo Reis
Dr. Eduardo Pontes Reis, MD is Vice President of Strategy in the Office of the CEO at Hippocratic AI, a Palo Alto-based generative AI healthcare company with $439M in total funding. A neuroradiologist and AI researcher, he bridges clinical medicine and artificial intelligence through leadership roles at Stanford's Center for Artificial Intelligence in Medicine and Imaging (AIMI) and Hospital Israelita Albert Einstein in Brazil, where he initiated the Health Story medical timeline platform and led AI development for diseases including tuberculosis, COVID-19, melanoma, and head CT analysis. He co-authored the BRAX Brazilian Chest X-ray Dataset published in Nature Scientific Data, built open-source tools for integrating AI plugins into LLMs (plugnplai, 228+ GitHub stars), and served as Founding Radiologist at Cognita Imaging — a Stanford AIMI spinoff acquired by Radiology Partners for $80M — before joining Hippocratic AI in early 2026.
Harpreet Mangat
Harpreet Mangat is a British-trained neurosurgeon turned Stanford MBA and McKinsey consultant who now serves as Chief Strategy Officer and Chief of Staff to the CEO at Hippocratic AI, a $3.5 billion healthcare AI company building clinically safe generative AI agents for patient engagement. His rare career arc - from brain surgery and ICU care during COVID-19, through venture capital and management consulting, to the frontier of healthcare AI - makes him one of the most credentialed operator-clinicians in the industry.